Cancer Drug Resistance
All Journals
Search Log In
Editor-in-Chief: Godefridus J. Peters
Indexing: ESCI, PMC, Scopus, CAS, CNKI, Dimensions, Lens, Embase,
Journal Rank: Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2023: 6.6 - Q1 [Pharmacology(medical)]
Submission to first decision: 63 days
Home Articles Special Issues Volumes Webinars Videos
Cancer Drug Resistance
Search Submit
Editor-in-Chief: Godefridus J. Peters
Journal Rank: Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2023: 6.6 - Q1 [Pharmacology(medical)]
Submission to first decision: 63 days
Home Articles Special Issues Volumes Webinars Videos

Cancer Drug Resistance

Mitochondria in colorectal cancer stem cells - a target in drug resistance

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

Targeting regulated cell death pathways in acute myeloid leukemia

Articles

Most Recent | Most Viewed | Most Downloaded

Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer

Samaneh TokhanbigliSamaneh Tokhanbigli, ... Brian Gregory George Oliver
Open Access Review DOI: 10.20517/cdr.2024.55 9 Sep 2024
Views: Downloads:
Download PDF

Research progress on the role and mechanism of circular RNA in drug resistance of head and neck squamous cell carcinoma

Hongli Zeng, ... Xuyu Zu
Open Access Review DOI: 10.20517/cdr.2024.57 1 Sep 2024
Views: Downloads:
Download PDF

The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancer

Meilan Zhang, ... Weige Tan
Open Access Review DOI: 10.20517/cdr.2024.62 19 Aug 2024
Views: Downloads:
Download PDF

The uniqueness of ABCB5 as a full transporter ABCB5FL and a half-transporter-like ABCB5β

Louise Gerard, Jean-Pierre GilletJean-Pierre Gillet
Open Access Review DOI: 10.20517/cdr.2024.56 6 Aug 2024
Views: Downloads:
Download PDF

Targeting NETosis: nature's alarm system in cancer progression

Yixia Liang, ... Phei Er Saw
Open Access Review DOI: 10.20517/cdr.2024.24 18 Jul 2024
Views: Downloads:
Download PDF

Venetoclax resistance: mechanistic insights and future strategies

Faustine Ong, ... Marina Y. Konopleva
Open Access Review DOI: 10.20517/cdr.2021.125 5 May 2022
Views: Downloads:
Download PDF

Improving HER2 testing reproducibility in HER2-low breast cancer

Elham Sajjadi, ... Nicola FuscoNicola Fusco
Open Access Opinion DOI: 10.20517/cdr.2022.29 31 Aug 2022
Views: Downloads:
Download PDF

Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces

Ahmad R. Safa
Open Access Review DOI: 10.20517/cdr.2022.20 1 Aug 2022
Views: Downloads:
Download PDF

Topic: Exosomes in Combating Cancer Drug Resistance

Dr. Farrukh Aqil; Dr. Ramesh Gupta

Submission Deadline: 15 Apr 2025

Published articles: 0

Topic: Resistance Challenges of Antibody-Drug Conjugates (ADCs) in Cancer Therapy

Prof. Ning Li; Dr. Shuhang Wang

Submission Deadline: 15 Mar 2025

Published articles: 0

For Reviewers

Peer Review Guidelines
For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Themed Collections
Resistance
Drug delivery
Nanomedicine
Tumor microenvironment
Immune checkpoint inhibitors
Target therapy
Immunotherapy
Radiotherapy
Ferroptosis
PARP inhibitors
MYC
ABC transporters
Autophagy
Metabolism
Mechanisms
Precision medicine
Extracellular vesicles
Stem cell
Biomarker
Ovarian cancer
Renal cell carcinoma
Prostate cancer
Breast cancer
Colorectal cancer
Myeloid leukemia
Non-small cell lung cancer
Pancreatic cancer
Head and neck cancer
Squamous cell carcinoma
Mitochondria
Topic: DNA Repair & Metabolism and Cancer Drug Resistance
Topic: Resistance to Cancer Immunotherapy: Mechanisms, Advances, Challenges and Opportunities
Topic: Resistance to Systemic Therapies in Renal Cell Carcinoma
Volume 7
Volume 6, Issue 4
Volume 6, Issue 3
Volume 6, Issue 2
Volume 6, Issue 1
Volume 5, Issue 4
Volume 5, Issue 3
Volume 5, Issue 2
Volume 5, Issue 1
Volume 4, Issue 4
Volume 4, Issue 3
Volume 4, Issue 2
Volume 4, Issue 1
Volume 3, Issue 4
Volume 3, Issue 3
Volume 3, Issue 2
Volume 3, Issue 1
Volume 2, Issue 4
Volume 2, Issue 3
Volume 2, Issue 2
Volume 2, Issue 1
Volume 1, Issue 4
Volume 1, Issue 3
Volume 1, Issue 2
Volume 1, Issue 1
Articles Collection
Related Journals

Extracellular Vesicles and Circulating Nucleic Acids

Editor-in-Chief: Yoke Peng Loh

Journal of Cancer Metastasis and Treatment

The Special Collection "Cancer Cell Plasticity in Therapy Resistance" Officially Launched and Open for Submissions
Cancer Drug Resistance Journal Announces Partnership with EACR-Boehringer Ingelheim Conference on MAP Kinase Pathway Regulation
The journal Cancer Drug Resistance has established a media partnership with the European Association for Cancer Research (EACR) and Boehringer Ingelheim for the upcoming EACR-Boehringer Ingelheim Conference: Drugging and Regulating the MAP Kinase Pathway.
Exciting News: Cancer Drug Resistance Journal’s New Impact Factor Reaches 4.6, Ranked in Q1 in Oncology!
We are pleased to announce that our journal, Cancer Drug Resistance (CDR), has obtained a new Impact Factor 2023 of 4.6, as reported by the Journal Citation Reports (JCR) released by Clarivate Analytics on June 20, 2024.
Journal of Cancer Drug Resistance Sees Significant Increase in 2023 CiteScore to 6.6
placing the journal in Q1 in the Pharmacology (medical) discipline
Four Editorial Board Members Promoted to Associate Editors at the Journal of Cancer Drug Resistance
Their promotion recognizes their exceptional contributions to the journal and their steadfast dedication to advancing research in the field of cancer drug resistance.
Professor Yehuda G Assaraf Promoted to Co-Editor-in-Chief of Cancer Drug Resistance Journal
We are delighted to announce the promotion of Prof. Yehuda G Assaraf to the position of Co-Editor-in-Chief of CDR juornal

Mitochondria in colorectal cancer stem cells - a target in drug resistance

Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma

P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance

Targeting regulated cell death pathways in acute myeloid leukemia

Venetoclax resistance: mechanistic insights and future strategies
Faustine Ong, ... Marina Y. Konopleva
Open Access | Review | 5 May 2022
Views: | Downloads:
Download PDF
Improving HER2 testing reproducibility in HER2-low breast cancer
Elham Sajjadi, ... Nicola FuscoNicola Fusco
Open Access | Opinion | 31 Aug 2022
Views: | Downloads:
Download PDF
Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces
Ahmad R. Safa
Open Access | Review | 1 Aug 2022
Views: | Downloads:
Download PDF

Topic: Exosomes in Combating Cancer Drug Resistance

Dr. Farrukh Aqil; Dr. Ramesh Gupta

Submission Deadline: 15 Apr 2025

Published articles: 0

Topic: Resistance Challenges of Antibody-Drug Conjugates (ADCs) in Cancer Therapy

Prof. Ning Li; Dr. Shuhang Wang

Submission Deadline: 15 Mar 2025

Published articles: 0

Related Journals

Extracellular Vesicles and Circulating Nucleic Acids

Editor-in-Chief: Yoke Peng Loh

Journal of Cancer Metastasis and Treatment

Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/
[email protected] Company Contact Us
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties